New approaches in the management of patients with chronic congestive heart failure

M Jessup1, S Brozena

  • 1Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Insights

Managing congestive heart failure (CHF) is costly. Evidence-based guidelines and newer therapies, including medical and surgical options, can improve patient outcomes and reduce healthcare expenses.

Area of Science:

  • Cardiology
  • Health Economics

Background:

  • Congestive heart failure (CHF) presents a significant and escalating economic challenge.
  • Existing evidence-based guidelines offer potential for cost savings and improved survival.
  • Emerging research clarifies the roles of novel therapies in disease management.

Purpose of the Study:

  • To review current evidence-based guidelines for managing congestive heart failure.
  • To explore the potential of existing and novel medical and surgical therapies.
  • To address the economic burden associated with heart failure care.

Main Methods:

  • Review of current medical and surgical treatment strategies for CHF.
  • Analysis of evidence-based guidelines for heart failure management.
  • Discussion of the economic implications of various therapeutic approaches.

Main Results:

  • Standard therapies (diuretics, ACE inhibitors, beta-blockers) improve symptoms, reduce hospitalizations, and enhance survival.
  • Angiotensin receptor antagonists and cytokine antagonists are under investigation for their roles.
  • Left ventricular assist device implantation shows potential for myocardial recovery and innovative surgical interventions.

Conclusions:

  • Implementing evidence-based guidelines can mitigate the economic burden of CHF.
  • Future strategies should integrate new knowledge while optimizing cost-effectiveness of treatments.
  • A judicious approach to drug selection is crucial to avoid unnecessary costs at all disease stages.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...